Shares of Opiant Pharmaceuticals (NASDAQ:OPNT) were flat after the company reported Q4 results. Quarterly Results Earnings per share decreased 180.00% over the past year to ($0.16), which missed the est

About Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug

The company has developed NARCAN, a Nasal Spray for treatment to reverse opioid overdoses. Opiant Pharmaceuticals Inc (NASDAQ: OPNT) has dosed the first subjects in a head-to-head clinical study comparing the effectiveness of its investigational opioid antagonist nasal nalmefene 2021-03-28 · Opiant Pharmaceuticals, Inc. Common Stock (OPNT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Opiant Pharmaceuticals has generated $0.20 earnings per share over the last year. Opiant Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 11th, 2021 based off prior year's report dates. Opiant Pharmaceuticals Earnings Estimates and Actuals by Quarter Opiant, New Delhi. 757 likes · 109 talking about this · 1 was here.

Opiant

* To buy US shares you must first complete and return a US Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal Opiant Pharmaceuticals, Inc. recently announced it has completed patient enrollment in its Phase 2 clinical trial of OPTN001, a naloxone nasal spray, for. View the latest Opiant Pharmaceuticals Inc. (OPNT) stock price, news, historical charts, analyst ratings and financial information from WSJ. Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Opiant Pharmaceuticals Inc have a median target of 40.00, with a high estimate of 42.00 Opiant Pharmaceuticals is a specialty pharmaceutical company developing treatments for substance use, addictive and eating disorders. Security Details. Opiant's top competitors are Amphastar Pharmaceuticals, Emergent BioSolutions and BioCorRx. See Opiant's revenue, employees, and funding info on Owler, 10 Dec 2020 Opiant Pharmaceuticals Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and Opiant Pharmaceuticals Inc is a specialty pharmaceutical company operating in the US. It develops pharmacological treatments for substance use, addictive and 15 Dec 2020 On December 10, 2020, Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company developing medicines to treat addictions and drug 9 Feb 2021 Opiant Pharmaceuticals Inc (NASDAQ: OPNT) doses the first patient in a confirmatory pharmacokinetic (PK) study evaluating OPNT003 (nasal 18 Dec 2020 Nagendra Singh and Aarti Chitkara.Opiant is Nagendra's brainchild and its beginnings were very humble.

2021-03-31 · SANTA MONICA, Calif., March 31, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, has been awarded the third and final tranche of $1.8 million from the total grant of 2021-01-11 · Opiant Pharmaceuticals Inc. SEC filings breakout by MarketWatch. View the OPNT U.S. Securities and Exchange Commission reporting information. Shares of Opiant Pharmaceuticals (NASDAQ:OPNT) were flat after the company reported Q3 results..

Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa.

At OPIANT BIOTECH LLP, Quality Assurance (QA) and Quality Control (QC) are two distinct processes that ensure our credibility. The professionals engaged in manufacturing & quality control have uncompromising commitment to Quality and consistency.

Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Opiant Pharmaceuticals Fourth Quarter and Full Year 2020 Financial Results Conference Call. Click here for webcast.

11 hours ago Köp aktier i Opiant Pharmaceuticals Inc - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Opiant Pharmaceuticals Fourth Quarter and Full Year 2020 Financial Results Conference Call. Click here for webcast. Jan 11 - Jan 15, 2021. 2021-03-09 2020-12-10 2021-04-07 2021-04-05 2021-03-31 2021-03-04 Opiant anticipates the potential to submit a New Drug Application for the drug and intranasal delivery device combination in 2020. Opiant retains full commercial rights to OPNT-003, and this development work is largely funded by a $7.4 million National Institutes of Health (NIH) grant.
Yotob e

For more information visit Få detaljerad information om Opiant Pharmaceuticals Inc (OPNT) aktie inklusive kurs, diagram, tekniska analyser, empirisk data, Opiant Pharma rapporter och mycket mer. 2021-03-31 · Opiant Pharmaceuticals, Inc., the company that developed NARCAN ® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. For more information, visit 2021-04-07 · OPNT | Complete Opiant Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. By David Bautz, PhD NASDAQ:OPNT READ THE FULL OPNT RESEARCH REPORT Financial Update On March 4, 2021, Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) announced financial results for the fourth quarter Mr. Pollack has been an investment banker and securities attorney at Banc of America Securities LLC and Sidley Austin LLP (formerly Brown & Wood LLP), respectively, and has previous asset management experience at Paragon Capital LP. 11 timmar sedan · Opiant Pharmaceuticals with ticker code (OPNT) now have 3 analysts in total covering the stock.

We are headquartered in Santa … OPIANT is a consulting company with focus on delivering Information Technology and business excellence through various software solutions. We are experts in developing easy-to-use, search-friendly, mobile-friendly, database driven web platforms and content management systems.We at Opiant, develop customised software solutions for variety of industries across the globe.
Bildskarmsglasogon

Description: Opiant Pharmaceuticals Inc is a specialty pharmaceutical company operating in the US. It develops pharmacological treatments for substance use, addictive and eating disorders. The company has developed NARCAN, a Nasal Spray for treatment to reverse opioid overdoses.

The company is developing additional therapies for opioid use disorder, including advancing the pre-clinical development of its heroin vaccine candidate, which was licensed in October 2016 from the Walter Reed Army Institute of Research and the National Institute on Drug Abuse (NIDA). Shares of Opiant Pharmaceuticals (NASDAQ:OPNT) were flat after the company reported Q4 results. Quarterly Results Earnings per share decreased 180.00% over the past year to ($0.16), which missed the est 2016-10-28 · Stock analysis for Opiant Pharmaceuticals Inc (OPNT:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

View the real-time OPNT price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Opiant against related stocks people have also bought.

The target price ranges between 44 and 38 calculating the average target price we see 41.33. Opiant Pharmaceuticals, Inc. Common Stock (OPNT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company.

Senaste smeknamn.